Mounjaro on Humana Basic Rx Plan (S5884-101)
tirzepatide injection
Covered, with prior authorization required.
Tier 3 (preferred brand). Quantity limit of 2 per 28 days.
$266.95
Patient pays / month, after deductible
$728.20
Patient pays / month, before the $615.00 deductible
$640.68
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
MOUNJARO 12.5 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $1,067.80 for a month. Other covered strengths are listed below.
Prior authRequired on all 6 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 6 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| MOUNJARO 15 mg/.5mL Injection, Solution | 3 | $267.04 | PA · 2 per 28 days |
| MOUNJARO 12.5 mg/.5mL Injection, Solution | 3 | $266.95 | PA · 2 per 28 days |
| MOUNJARO 10 mg/.5mL Injection, Solution | 3 | $267.00 | PA · 2 per 28 days |
| MOUNJARO 7.5 mg/.5mL Injection, Solution | 3 | $267.19 | PA · 2 per 28 days |
| MOUNJARO 5 mg/.5mL Injection, Solution | 3 | $267.29 | PA · 2 per 28 days |
| MOUNJARO 2.5 mg/.5mL Injection, Solution | 3 | $267.33 | PA · 2 per 28 days |
Other GLP-1s on this plan
Verify with the plan before prescribing or filling. Member services: (800)281-6918. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5884-101